The Haemophilus Influenzae Type B Vaccine Market is supported by the expansion of national immunization programs. Incorporating Hib-containing vaccines into routine vaccination schedules helps healthcare systems reach eligible populations and reduce the risk of preventable infections. The Haemophilus Influenzae Type B Vaccine Market size is expected to reach US$ 2.76 billion by 2034 from US$...